| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| NF-kappa B | 34 | 2007 | 358 | 3.060 |
Why?
|
| Curcumin | 13 | 2012 | 118 | 1.730 |
Why?
|
| Apoptosis | 23 | 2016 | 1568 | 1.340 |
Why?
|
| Antineoplastic Agents | 15 | 2016 | 1019 | 1.080 |
Why?
|
| Commiphora | 3 | 2016 | 5 | 1.040 |
Why?
|
| Neoplasms | 14 | 2016 | 1377 | 0.980 |
Why?
|
| Pregnenediones | 3 | 2016 | 5 | 0.960 |
Why?
|
| I-kappa B Kinase | 13 | 2006 | 51 | 0.840 |
Why?
|
| Tumor Necrosis Factor-alpha | 15 | 2007 | 384 | 0.660 |
Why?
|
| Cyclin D1 | 8 | 2006 | 44 | 0.620 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2006 | 133 | 0.600 |
Why?
|
| I-kappa B Proteins | 9 | 2006 | 36 | 0.560 |
Why?
|
| Isoenzymes | 6 | 2004 | 168 | 0.560 |
Why?
|
| Lung Neoplasms | 6 | 2006 | 495 | 0.540 |
Why?
|
| Down-Regulation | 14 | 2007 | 456 | 0.520 |
Why?
|
| Cyclooxygenase 2 | 13 | 2007 | 107 | 0.500 |
Why?
|
| Cyclooxygenase Inhibitors | 3 | 2007 | 28 | 0.500 |
Why?
|
| Gene Expression | 7 | 2012 | 701 | 0.500 |
Why?
|
| Transcription Factors | 5 | 2012 | 735 | 0.470 |
Why?
|
| Triterpenes | 2 | 2006 | 18 | 0.440 |
Why?
|
| Phosphorylation | 15 | 2006 | 986 | 0.430 |
Why?
|
| Enzyme Activation | 15 | 2007 | 462 | 0.420 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 6 | 2004 | 41 | 0.420 |
Why?
|
| Plant Gums | 2 | 2016 | 7 | 0.410 |
Why?
|
| Sulfonamides | 2 | 2004 | 91 | 0.410 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2004 | 165 | 0.390 |
Why?
|
| Matrix Metalloproteinase 9 | 7 | 2006 | 95 | 0.390 |
Why?
|
| Gene Expression Regulation | 5 | 2012 | 1070 | 0.350 |
Why?
|
| Cell Line, Tumor | 16 | 2016 | 2676 | 0.350 |
Why?
|
| Humans | 52 | 2021 | 43102 | 0.320 |
Why?
|
| S Phase | 3 | 2007 | 36 | 0.310 |
Why?
|
| Plant Extracts | 4 | 2008 | 302 | 0.300 |
Why?
|
| Cell Proliferation | 10 | 2016 | 1455 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-akt | 8 | 2007 | 299 | 0.300 |
Why?
|
| Osteoclasts | 4 | 2007 | 28 | 0.280 |
Why?
|
| Smoking | 3 | 2004 | 1024 | 0.280 |
Why?
|
| Anticarcinogenic Agents | 2 | 2006 | 77 | 0.280 |
Why?
|
| Klebsiella pneumoniae | 2 | 2018 | 26 | 0.270 |
Why?
|
| Dust | 2 | 2018 | 57 | 0.260 |
Why?
|
| Animals | 21 | 2021 | 16992 | 0.260 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2018 | 63 | 0.260 |
Why?
|
| Transcription Factor RelA | 7 | 2006 | 42 | 0.260 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2007 | 97 | 0.260 |
Why?
|
| Genes, Reporter | 7 | 2007 | 148 | 0.250 |
Why?
|
| G1 Phase | 2 | 2005 | 31 | 0.250 |
Why?
|
| Oleanolic Acid | 1 | 2006 | 6 | 0.240 |
Why?
|
| Tumor Necrosis Factors | 1 | 2006 | 13 | 0.240 |
Why?
|
| Carcinogens | 2 | 2004 | 126 | 0.240 |
Why?
|
| Chronic Disease | 2 | 2008 | 549 | 0.240 |
Why?
|
| Drug Design | 1 | 2007 | 186 | 0.240 |
Why?
|
| Membrane Proteins | 8 | 2007 | 561 | 0.240 |
Why?
|
| Fenretinide | 1 | 2005 | 9 | 0.240 |
Why?
|
| Signal Transduction | 8 | 2007 | 2157 | 0.240 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2005 | 5 | 0.240 |
Why?
|
| Cell Survival | 9 | 2007 | 945 | 0.230 |
Why?
|
| Biological Factors | 1 | 2004 | 6 | 0.220 |
Why?
|
| Escherichia coli | 2 | 2018 | 460 | 0.220 |
Why?
|
| Spices | 1 | 2004 | 9 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 6 | 2006 | 526 | 0.210 |
Why?
|
| Stilbenes | 4 | 2006 | 44 | 0.210 |
Why?
|
| Antineoplastic Agents, Phytogenic | 4 | 2008 | 134 | 0.210 |
Why?
|
| DNA-Binding Proteins | 6 | 2010 | 561 | 0.210 |
Why?
|
| Atherosclerosis | 1 | 2005 | 169 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 257 | 0.200 |
Why?
|
| Plant Roots | 1 | 2005 | 180 | 0.200 |
Why?
|
| Neoplasm Proteins | 2 | 2004 | 228 | 0.200 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 247 | 0.190 |
Why?
|
| Active Transport, Cell Nucleus | 4 | 2006 | 60 | 0.180 |
Why?
|
| Precancerous Conditions | 3 | 2007 | 83 | 0.180 |
Why?
|
| Receptors, Tumor Necrosis Factor | 4 | 2006 | 37 | 0.170 |
Why?
|
| Interleukin-1 | 4 | 2006 | 39 | 0.170 |
Why?
|
| Metals, Heavy | 1 | 2021 | 71 | 0.160 |
Why?
|
| Epithelial Cells | 3 | 2018 | 434 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 3 | 2006 | 290 | 0.160 |
Why?
|
| Cyclonic Storms | 1 | 2021 | 80 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 2 | 2016 | 139 | 0.160 |
Why?
|
| Soil Pollutants | 1 | 2021 | 105 | 0.160 |
Why?
|
| Diet | 1 | 2006 | 826 | 0.160 |
Why?
|
| Inflammation | 4 | 2006 | 758 | 0.150 |
Why?
|
| Neoplasm Metastasis | 3 | 2005 | 237 | 0.150 |
Why?
|
| Blotting, Western | 7 | 2007 | 883 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2007 | 968 | 0.140 |
Why?
|
| Eukaryotic Cells | 1 | 2018 | 35 | 0.140 |
Why?
|
| Cell Line | 7 | 2018 | 1410 | 0.140 |
Why?
|
| Biofilms | 2 | 2017 | 184 | 0.140 |
Why?
|
| Models, Biological | 3 | 2007 | 712 | 0.140 |
Why?
|
| Cell Division | 5 | 2004 | 311 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2007 | 183 | 0.130 |
Why?
|
| Enterococcus faecalis | 1 | 2018 | 53 | 0.130 |
Why?
|
| Jurkat Cells | 4 | 2004 | 87 | 0.130 |
Why?
|
| Environmental Exposure | 2 | 2017 | 256 | 0.130 |
Why?
|
| Membrane Glycoproteins | 4 | 2006 | 224 | 0.120 |
Why?
|
| Transcription Factor AP-1 | 2 | 2007 | 34 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2006 | 137 | 0.120 |
Why?
|
| Mouth Neoplasms | 2 | 2007 | 60 | 0.120 |
Why?
|
| Carcinoma, Small Cell | 2 | 2006 | 7 | 0.120 |
Why?
|
| U937 Cells | 3 | 2006 | 31 | 0.120 |
Why?
|
| Okadaic Acid | 3 | 2004 | 16 | 0.120 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 2004 | 43 | 0.120 |
Why?
|
| Resins, Plant | 1 | 2016 | 5 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 347 | 0.120 |
Why?
|
| Air Microbiology | 1 | 2015 | 17 | 0.120 |
Why?
|
| Molecular Structure | 2 | 2016 | 570 | 0.120 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 5 | 2007 | 84 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2007 | 1124 | 0.110 |
Why?
|
| Multiple Myeloma | 2 | 2006 | 48 | 0.110 |
Why?
|
| Transcription, Genetic | 3 | 2010 | 592 | 0.110 |
Why?
|
| Carrier Proteins | 3 | 2006 | 321 | 0.110 |
Why?
|
| Cell Nucleus | 3 | 2006 | 383 | 0.110 |
Why?
|
| Air Pollutants | 1 | 2015 | 130 | 0.100 |
Why?
|
| Luciferases | 2 | 2004 | 71 | 0.100 |
Why?
|
| Pyrazoles | 2 | 2004 | 103 | 0.100 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2004 | 10 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2006 | 146 | 0.100 |
Why?
|
| Receptors, Growth Factor | 1 | 2012 | 11 | 0.100 |
Why?
|
| Medicine, Traditional | 1 | 2012 | 23 | 0.100 |
Why?
|
| Proteins | 3 | 2004 | 382 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 7 | 2007 | 508 | 0.090 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 3 | 2006 | 4 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2003 | 192 | 0.090 |
Why?
|
| RANK Ligand | 3 | 2006 | 19 | 0.090 |
Why?
|
| Poly(ADP-ribose) Polymerases | 3 | 2010 | 79 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 140 | 0.090 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2010 | 3 | 0.080 |
Why?
|
| Drug Synergism | 3 | 2006 | 195 | 0.080 |
Why?
|
| Tobacco, Smokeless | 2 | 2007 | 19 | 0.080 |
Why?
|
| Protons | 1 | 2010 | 94 | 0.080 |
Why?
|
| Cyclin E | 2 | 2006 | 14 | 0.080 |
Why?
|
| Osteogenesis | 2 | 2006 | 57 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2006 | 23 | 0.080 |
Why?
|
| Medicine, Ayurvedic | 2 | 2006 | 10 | 0.080 |
Why?
|
| DNA Repair | 1 | 2010 | 198 | 0.070 |
Why?
|
| Genes, myc | 2 | 2006 | 31 | 0.070 |
Why?
|
| Boronic Acids | 2 | 2006 | 21 | 0.070 |
Why?
|
| Pyrazines | 2 | 2006 | 32 | 0.070 |
Why?
|
| Immunohistochemistry | 6 | 2007 | 934 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 2 | 2006 | 102 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2007 | 259 | 0.070 |
Why?
|
| Antigens, CD20 | 1 | 2007 | 3 | 0.070 |
Why?
|
| Coculture Techniques | 2 | 2018 | 109 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 2 | 2 | 2004 | 16 | 0.070 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2006 | 51 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2006 | 307 | 0.070 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2004 | 20 | 0.070 |
Why?
|
| DNA, Neoplasm | 2 | 2004 | 92 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2007 | 62 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2006 | 21 | 0.060 |
Why?
|
| Doxorubicin | 2 | 2006 | 97 | 0.060 |
Why?
|
| Rotenone | 1 | 2006 | 17 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 56 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2007 | 59 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2007 | 157 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2007 | 83 | 0.060 |
Why?
|
| Cell Migration Inhibition | 1 | 2006 | 5 | 0.060 |
Why?
|
| Withania | 1 | 2006 | 6 | 0.060 |
Why?
|
| Ergosterol | 1 | 2006 | 12 | 0.060 |
Why?
|
| Biphenyl Compounds | 1 | 2006 | 53 | 0.060 |
Why?
|
| DNA Primers | 2 | 2005 | 294 | 0.060 |
Why?
|
| TNF Receptor-Associated Death Domain Protein | 1 | 2006 | 1 | 0.060 |
Why?
|
| Lignans | 1 | 2006 | 22 | 0.060 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2006 | 11 | 0.060 |
Why?
|
| DNA Replication | 1 | 2007 | 148 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2006 | 1621 | 0.060 |
Why?
|
| Drug Delivery Systems | 2 | 2006 | 277 | 0.060 |
Why?
|
| Chemoprevention | 1 | 2006 | 41 | 0.060 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 43 | 0.060 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2006 | 53 | 0.060 |
Why?
|
| Oncogene Protein v-akt | 1 | 2005 | 20 | 0.060 |
Why?
|
| Glioma | 1 | 2007 | 96 | 0.060 |
Why?
|
| Tetrazoles | 1 | 2006 | 46 | 0.060 |
Why?
|
| Leukemia | 1 | 2006 | 54 | 0.060 |
Why?
|
| Lipopolysaccharides | 2 | 2004 | 239 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2007 | 186 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2006 | 47 | 0.060 |
Why?
|
| Mutation | 2 | 2007 | 1177 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2003 | 200 | 0.060 |
Why?
|
| India | 1 | 2005 | 108 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2005 | 63 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2005 | 50 | 0.060 |
Why?
|
| Imidazoles | 1 | 2006 | 142 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2005 | 58 | 0.060 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2005 | 69 | 0.060 |
Why?
|
| Paclitaxel | 1 | 2005 | 64 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 296 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 4 | 2005 | 54 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 652 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2006 | 74 | 0.060 |
Why?
|
| Vegetables | 1 | 2006 | 147 | 0.060 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2004 | 3 | 0.050 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2004 | 27 | 0.050 |
Why?
|
| Fruit | 1 | 2006 | 178 | 0.050 |
Why?
|
| Immunity | 1 | 2004 | 61 | 0.050 |
Why?
|
| Biology | 1 | 2004 | 20 | 0.050 |
Why?
|
| Daunorubicin | 1 | 2004 | 3 | 0.050 |
Why?
|
| Melanoma | 1 | 2005 | 110 | 0.050 |
Why?
|
| Smoke | 1 | 2004 | 42 | 0.050 |
Why?
|
| Disease | 1 | 2004 | 21 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2004 | 38 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2005 | 389 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2003 | 7 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 423 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2004 | 204 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 185 | 0.050 |
Why?
|
| Piperazines | 1 | 2004 | 120 | 0.050 |
Why?
|
| Temperature | 1 | 2004 | 313 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2004 | 139 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 196 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2002 | 168 | 0.050 |
Why?
|
| Transfection | 1 | 2003 | 532 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 218 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2003 | 1271 | 0.040 |
Why?
|
| Rivers | 1 | 2021 | 51 | 0.040 |
Why?
|
| Mice | 6 | 2010 | 6644 | 0.040 |
Why?
|
| Hydrogen Peroxide | 2 | 2017 | 190 | 0.040 |
Why?
|
| Hypertension | 1 | 2007 | 835 | 0.040 |
Why?
|
| Oxidative Stress | 2 | 2017 | 1003 | 0.040 |
Why?
|
| Soil | 1 | 2021 | 171 | 0.040 |
Why?
|
| Environmental Monitoring | 1 | 2021 | 230 | 0.040 |
Why?
|
| Brain | 1 | 2006 | 1472 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 1001 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2017 | 60 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 760 | 0.030 |
Why?
|
| Environmental Microbiology | 1 | 2017 | 27 | 0.030 |
Why?
|
| Female | 6 | 2007 | 24698 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 71 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2010 | 536 | 0.030 |
Why?
|
| Time Factors | 3 | 2007 | 1857 | 0.030 |
Why?
|
| Syndecan-1 | 2 | 2006 | 9 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2010 | 223 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2010 | 241 | 0.030 |
Why?
|
| Lung | 1 | 2018 | 492 | 0.030 |
Why?
|
| Air Pollution, Indoor | 1 | 2015 | 53 | 0.030 |
Why?
|
| Interleukin-8 | 2 | 2005 | 74 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2007 | 173 | 0.030 |
Why?
|
| Particulate Matter | 1 | 2015 | 83 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2006 | 165 | 0.030 |
Why?
|
| Male | 7 | 2010 | 23409 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2005 | 411 | 0.020 |
Why?
|
| Base Sequence | 2 | 2005 | 983 | 0.020 |
Why?
|
| Ligands | 2 | 2003 | 388 | 0.020 |
Why?
|
| Aged | 4 | 2007 | 8214 | 0.020 |
Why?
|
| Hela Cells | 2 | 2002 | 376 | 0.020 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2010 | 3 | 0.020 |
Why?
|
| Endonucleases | 1 | 2010 | 18 | 0.020 |
Why?
|
| DNA | 2 | 2003 | 592 | 0.020 |
Why?
|
| Middle Aged | 4 | 2007 | 12222 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 694 | 0.020 |
Why?
|
| DNA Damage | 1 | 2010 | 356 | 0.020 |
Why?
|
| Nitrosamines | 1 | 2007 | 11 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2007 | 49 | 0.020 |
Why?
|
| Genes, erbB-1 | 1 | 2006 | 2 | 0.020 |
Why?
|
| Bone Resorption | 1 | 2007 | 22 | 0.020 |
Why?
|
| Thalidomide | 1 | 2006 | 6 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 236 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2007 | 154 | 0.020 |
Why?
|
| Genes, ras | 1 | 2006 | 24 | 0.020 |
Why?
|
| Synaptotagmin I | 1 | 2006 | 3 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2006 | 76 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 224 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 704 | 0.020 |
Why?
|
| Interleukins | 1 | 2006 | 40 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2006 | 81 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2006 | 11 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2006 | 150 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2006 | 29 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 227 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2006 | 70 | 0.010 |
Why?
|
| Allyl Compounds | 1 | 2006 | 55 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2006 | 124 | 0.010 |
Why?
|
| Serine | 1 | 2006 | 79 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 34 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 140 | 0.010 |
Why?
|
| Phenols | 1 | 2006 | 107 | 0.010 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2005 | 24 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 98 | 0.010 |
Why?
|
| Veratrum | 1 | 2004 | 1 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2006 | 161 | 0.010 |
Why?
|
| Protein Transport | 1 | 2005 | 296 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 181 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 187 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2005 | 408 | 0.010 |
Why?
|
| Adult | 3 | 2007 | 13872 | 0.010 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2004 | 2 | 0.010 |
Why?
|
| Philadelphia Chromosome | 1 | 2004 | 3 | 0.010 |
Why?
|
| Terminal Repeat Sequences | 1 | 2004 | 8 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2004 | 8 | 0.010 |
Why?
|
| Anthracyclines | 1 | 2004 | 8 | 0.010 |
Why?
|
| Syndecans | 1 | 2003 | 2 | 0.010 |
Why?
|
| Karyotyping | 1 | 2004 | 45 | 0.010 |
Why?
|
| Cyclin D3 | 1 | 2003 | 3 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2003 | 4 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2003 | 27 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 2003 | 36 | 0.010 |
Why?
|
| Cyclins | 1 | 2003 | 34 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 138 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 150 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2003 | 55 | 0.010 |
Why?
|
| Dimerization | 1 | 2003 | 112 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2003 | 55 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2003 | 49 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2004 | 196 | 0.010 |
Why?
|
| Protein Binding | 1 | 2007 | 1082 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 79 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2003 | 99 | 0.010 |
Why?
|
| Benzamides | 1 | 2004 | 81 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2003 | 35 | 0.010 |
Why?
|
| Thiazoles | 1 | 2003 | 76 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 458 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 152 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 532 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 2002 | 12 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 155 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2003 | 238 | 0.010 |
Why?
|
| Cell Death | 1 | 2003 | 278 | 0.010 |
Why?
|
| Ceramides | 1 | 2002 | 44 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2002 | 93 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 108 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 2002 | 43 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2002 | 34 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 139 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 105 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 148 | 0.010 |
Why?
|
| Prognosis | 1 | 2004 | 861 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 458 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 638 | 0.010 |
Why?
|
| Peptides | 1 | 2003 | 372 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 281 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 780 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 2853 | 0.010 |
Why?
|
| Child | 1 | 2004 | 3443 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 1723 | 0.010 |
Why?
|
| Adolescent | 1 | 2004 | 6081 | 0.010 |
Why?
|